Nicolas Maubeuge

Poitiers, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system.

Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: December 14, 2022

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

Journal: BMC medical research methodology

Published: January 14, 2022

Validation of a Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) and comparison with reference batteries.

Validation of a Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) and comparison with reference batteries.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: November 12, 2021

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.

Journal: Neurology

Published: November 05, 2021

Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.

Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.

Journal: CNS drugs

Published: August 16, 2021

CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments.

CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 21, 2021

The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies.

The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies.

Journal: Multiple sclerosis and related disorders

Published: January 31, 2021

Untreated patients with multiple sclerosis: A study of French expert centers.

Untreated patients with multiple sclerosis: A study of French expert centers.

Journal: European journal of neurology

Published: January 17, 2021

Determinants of therapeutic lag in multiple sclerosis.

Determinants of therapeutic lag in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: January 11, 2021

Hematopoietic stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: French experience about four patients, under the behalf of French society for bone marrow transplantation.

Hematopoietic stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: French experience about four patients, under the behalf of French society for bone marrow transplantation.

Journal: Journal of neurology

Published: November 26, 2020

Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

Journal: Multiple sclerosis and related disorders

Published: September 11, 2020

Autologous hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyneuropathy

Autologous hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyneuropathy

Journal: La Revue de medecine interne

Published: September 01, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026